Crossmark Global Holdings reports $7.69 billion in assets
Crossmark Global Holdings, Inc. reveals $7.69 billion in assets under management in its latest 13F-HR filing, highlighting key investment positions.
HSBC USA Inc. announces new Autocallable Notes offering
HSBC USA Inc. files pricing supplement for Autocallable Contingent Income Barrier Notes, impacting the national commercial banking sector.
Westbourne Flex, LLC Completes $38.3 Million Private Offering
Westbourne Flex, LLC has completed a $38.3 million private offering to support its growth in the commercial sector, attracting 24 accredited investors.
Aerus Capital Partners amends private offering details
Aerus Capital Partners, LP has amended its private offering under Rule 506(b) to clarify investment terms and attract more investors.
Van Kampen Unit Trusts Taxable Income Series 416 Files Annual Report
Van Kampen Unit Trusts Taxable Income Series 416 reports no new sales and significant redemptions in its annual filing, reflecting its current financial operations.
Morgan Stanley Finance files pricing supplement for notes
Morgan Stanley Finance LLC announces a pricing supplement for market-linked notes due in 2031, signaling diversification in investment offerings.
BofA Finance LLC Files Preliminary Pricing Supplement for New Securities
BofA Finance LLC has filed a preliminary pricing supplement for market-linked securities, guaranteed by Bank of America Corp, signaling a strategic move in the banking sector.
GS Finance Corp. files for new S&P 500-linked notes
GS Finance Corp. has filed a preliminary pricing supplement for new notes linked to the S&P 500 Futures Adaptive Response Index, signaling innovation in the sector.
806 Manhattan Investors LLC Launches $6 Million Offering
806 Manhattan Investors LLC has initiated a $6 million offering, raising $3.2 million to date, opening opportunities for investors in the residential sector.
Van Kampen Unit Trusts Taxable Income Series 418 Reports Annual Filing
Van Kampen Unit Trusts Taxable Income Series 418 reveals significant redemptions in its annual filing, impacting the investment trust sector.
Invesco Unit Trusts Series 2481 Reports $24M in Securities Sales
Invesco Unit Trusts Series 2481 files 24F-2NT, reporting $24M in securities sales, signaling strong demand in the investment management sector.
Invesco Unit Trusts Series 2482 Reports Strong Year-End Results
Invesco Unit Trusts Series 2482 reports over $11.9 million in net sales in its latest filing, marking the end of its fiscal year.
Van Kampen Unit Trusts reports annual filing with redemptions
Van Kampen Unit Trusts Taxable Income Series 352 files its annual report, showing no new sales and significant redemptions, impacting its future strategy.
Invesco Unit Trusts Series 2480 Completes Annual Filing
Invesco Unit Trusts Series 2480 has filed its annual 24F-2NT, reporting net sales of $16.9 million and marking the end of its fiscal year.
Citigroup files for Medium-Term Senior Notes linked to SOFR
Citigroup Inc. files a preliminary pricing supplement for its Medium-Term Senior Notes linked to the synthetic 2Y2Y SOFR CMS rate, highlighting investment risks.
Van Kampen Unit Trusts reports annual securities redemption
Van Kampen Unit Trusts Taxable Income Series 424 reports $165,423 in securities redeemed and significant redemption credits for future use in its annual filing.
Van Kampen Unit Trusts Taxable Income Series 425 Files Annual Report
Van Kampen Unit Trusts Taxable Income Series 425 has filed its annual report, detailing redemption activity and financial standing for the fiscal year.
P2 Nexxt Offshore Fund LP amends private offering details
P2 Nexxt Offshore Fund LP has amended its private offering, raising over $43 million, highlighting trends in the hedge fund sector.
FT 13294 Files Effective Amendment for Aerospace Portfolio
FT 13294 has filed an effective amendment to its registration statement, allowing it to offer units in its Aerospace & Defense Portfolio.
CytoDyn Inc. announces leadership change in proxy filing
CytoDyn Inc. reveals a leadership change in its latest proxy filing, indicating a strategic shift for the pharmaceutical company.